Pursuant to Regulation 34(1) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the FY 2024-25.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
KMS Medisurgi Ltd submitted its Annual Report for FY 2024-25 and the notice for its 27th AGM scheduled on September 30, 2025. Revenue rose marginally to Rs. 1,393.86 Lakhs from Rs. 1,388.46 Lakhs in FY24, while profit after tax dipped slightly to Rs. 43.98 Lakhs from Rs. 45.38 Lakhs. The Board has recommended a final dividend of Rs. 0.05 (0.5%) per equity share. The company plans to expand into adhesive tapes for automotive and electrical applications. The company also proposes appointing M/s. Naveen Karn & Co. as Secretarial Auditors for five years (FY 2025-26 to FY 2029-30), and re-appoints Mr. Gaurang Kanakia as a director liable to retire by rotation. The company secretary was changed during the year, with Pooja Soni replacing Pavan Kumar Gupta.
Flat revenue growth and a small dip in PAT signal stagnant core performance; the modest 0.5% dividend is largely symbolic. New product expansion into automotive/electrical adhesives and a fresh secretarial auditor appointment are routine governance updates with no material near-term effect on shareholders.